Assessment of COPD exacerbation
Exacerbation severity in patients with chronic obstructive pulmonary disease (COPD) can be reliably assessed with the COPD Assessment Test™ (CAT), according to a new study from the UK.
Exacerbation severity in patients with chronic obstructive pulmonary disease (COPD) can be reliably assessed with the COPD Assessment Test™ (CAT), according to a new study from the UK.
Researchers in the U.K. report that non-restorative sleep is the strongest, independent predictor of widespread pain onset among adults over the age of 50.
New interim analysis study findings presented for the first time today at the 55th American Society of Hematology (ASH) Annual Meeting in New Orleans suggest bendamustine and rituximab… read more.
A new study shows that exposure to secondhand smoke at home or in the car dramatically increases the odds of children being readmitted to the hospital within a… read more.
by Bruce Sylvester – Gabapentin, a treatment for epilepsy and neuropathic pain, appears to be safe and effective for treating alcohol dependence, researchers reported in JAMA Internal Medicine on… read more.
by Bruce Sylvester – A new analysis of over 1 million hospital admissions in US hospitals revealed that over half of all nonsurgical patients were prescribed opioids during… read more.
Discussion of the abstract by Dr Zoran Gatalica, Adjunct Professor of Pathology at Creighton University School of Medicine .
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Anti-clotting agent helps reduce the risk of intraprocedural events during percutaneous coronary intervention.
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with… read more.
Report from the (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. A clinical trial shows that rapidly cooling patients who have suffered ST-elevation myocardial infarction (STEMI,… read more.
Report from the Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium, 27 October – 1 November, San Francisco. Results of the EUROMAX trial presented at TCT 2013; findings simultaneously published… read more.
by Esther Drain reporting on the presentation by Dr Timothy Price – A randomized, multicenter, open-label, phase 3 study of panitumumab (pmab) vs cetuximab (cmab) for previously treated… read more.
Advertisment